CHI Advisors LLC
- SEC CIK
- 0001791468
- Latest filing
- Nov 13, 2023
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 11, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 18
- −3 vs. Q1 2021
- Portfolio value
- $429.9M
- −$69.6M (−13.9%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RPTXRepare Therapeutics Inc. | COM | 2,539,644 | $79.2M | 18.4% | −21,059−0.8% | Reduced | History |
| RXDXPrometheus Biosciences, Inc. | COM | 2,852,009 | $70.0M | 16.3% | −22,023−0.8% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,367,888 | $69.0M | 16.0% | +43,093+1.9% | Added | History |
| CGEMCullinan Therapeutics, Inc. | COM | 2,242,841 | $57.8M | 13.4% | +40,434+1.8% | Added | History |
| Vectivbio Hldg AGH9060V101 | ORD SHS | 2,585,986 | $30.2M | 7.0% | +2,585,986 | New | – |
| ONCROncorus, Inc. | COM | 1,735,979 | $24.0M | 5.6% | −35,807−2.0% | Reduced | History |
| ORTXOrchard Therapeutics plc | ADS | 4,081,972 | $17.9M | 4.2% | +30,000+0.7% | Added | History |
| INZYInozyme Pharma, Inc. | COM | 927,264 | $15.8M | 3.7% | 00.0% | Unchanged | History |
| LRMRLarimar Therapeutics, Inc. | COM | 1,515,148 | $14.9M | 3.5% | 00.0% | Unchanged | History |
| IMAImageneBio, Inc. | COM | 814,756 | $11.4M | 2.7% | 00.0% | Unchanged | History |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 1,379,843 | $11.2M | 2.6% | −4,900−0.4% | Reduced | – |
| AKUSAkouos, Inc. | COM | 858,027 | $10.8M | 2.5% | 00.0% | Unchanged | History |
| DTILPrecision Biosciences Inc | COM | 651,729 | $8.16M | 1.9% | −39,900−5.8% | Reduced | History |
| KROSKeros Therapeutics, Inc. | COM | 116,406 | $4.94M | 1.2% | −284,062−70.9% | Reduced | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 719,132 | $1.92M | 0.4% | +40,000+5.9% | Added | History |
| GTHXG1 Therapeutics, Inc. | COM | 50,000 | $1.10M | 0.3% | 00.0% | Unchanged | History |
| OVIDOvid Therapeutics Inc. | COM | 218,510 | $854.0K | 0.2% | −29,000−11.7% | Reduced | History |
| KZRKezar Life Sciences, Inc. | COM | 146,680 | $796.0K | 0.2% | −27,489−15.8% | Reduced | History |
Sold out since Q1 2021 (4)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| GBTGlobal Blood Therapeutics, Inc. | COM | 15,000 | $611.0K | 0.1% | History |
| ADVMAdverum Biotechnologies, Inc. | COM | 40,209 | $396.0K | 0.1% | History |
| BPMCBlueprint Medicines Corp | COM | 3,500 | $340.0K | 0.1% | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 2,000 | $228.0K | <0.1% | History |